Estimating the incidence, prevalence and true cost of asthma in the UK: secondary analysis of national stand-alone and linked databases in England, Northern Ireland, Scotland and Wales-a study protocol.
Estimating the incidence, prevalence and true cost of asthma in the UK: secondary analysis of national stand-alone and linked databases in England, Northern Ireland, Scotland and Wales-a study protocol.
复制标题
DOI：
10.1136/bmjopen-2014-006647
复制
发表时间：
2014-11-04
期刊：
影响因子：
2.9
通讯作者：
Burden and True Cost of Asthma in the UK Research Team
中科院分区：
文献类型：
--
作者：
Mukherjee M;Gupta R;Farr A;Heaven M;Stoddart A;Nwaru BI;Fitzsimmons D;Chamberlain G;Bandyopadhyay A;Fischbacher C;Dibben C;Shields M;Phillips C;Strachan D;Davies G;McKinstry B;Sheikh A;Burden and True Cost of Asthma in the UK Research Team
哮喘现在是英国最常见的长期疾病之一。因此，必须对医疗保健和社会成本进行全面评估，以便为护理提供和规划决策提供信息。我们计划在之前对全国哮喘患病率和成本估计的基础上，填补先前确定的与医疗保健相关的数据空白，并扩大调查范围以包括社会成本。这项工作将首次对全英国范围内的哮喘费用进行估计。在英国及其成员国（即英格兰、北爱尔兰、苏格兰和威尔士）的哮喘背景下，我们力求：（1）对发病率、患病率和医疗保健利用率的估计进行详细概述； (2) 估计健康和社会成本； (3) 确定任何剩余的信息差距，并探索填补这些差距的可行性；(4) 提供对未来研究的见解，这些研究有可能为政策变化提供信息，从而提供更具成本效益的护理。将对来自国家健康调查、初级保健、处方、紧急护理、医院、死亡率和行政数据源的数据进行二次分析，以估计哮喘的患病率、医疗保健利用率和结果。将进行数据链接和经济建模，以试图填补数据缺口并估算成本。将为每个英国成员国单独计算患病率和成本估算，然后将这些数据汇总以生成英国范围内的估算。已获得 NHS 苏格兰信息服务部隐私咨询委员会、安全匿名信息链接协作审查系统、NHS 苏格兰东南部研究道德服务处和爱丁堡大学人口健康科学研究中心道德委员会的批准。我们将为英国哮喘协会制作一份报告，向同行评审期刊提交论文并构建交互式地图。
Asthma is now one of the most common long-term conditions in the UK. It is therefore important to develop a comprehensive appreciation of the healthcare and societal costs in order to inform decisions on care provision and planning. We plan to build on our earlier estimates of national prevalence and costs from asthma by filling the data gaps previously identified in relation to healthcare and broadening the field of enquiry to include societal costs. This work will provide the first UK-wide estimates of the costs of asthma. In the context of asthma for the UK and its member countries (ie, England, Northern Ireland, Scotland and Wales), we seek to: (1) produce a detailed overview of estimates of incidence, prevalence and healthcare utilisation; (2) estimate health and societal costs; (3) identify any remaining information gaps and explore the feasibility of filling these and (4) provide insights into future research that has the potential to inform changes in policy leading to the provision of more cost-effective care. Secondary analyses of data from national health surveys, primary care, prescribing, emergency care, hospital, mortality and administrative data sources will be undertaken to estimate prevalence, healthcare utilisation and outcomes from asthma. Data linkages and economic modelling will be undertaken in an attempt to populate data gaps and estimate costs. Separate prevalence and cost estimates will be calculated for each of the UK-member countries and these will then be aggregated to generate UK-wide estimates. Approvals have been obtained from the NHS Scotland Information Services Division's Privacy Advisory Committee, the Secure Anonymised Information Linkage Collaboration Review System, the NHS South-East Scotland Research Ethics Service and The University of Edinburgh's Centre for Population Health Sciences Research Ethics Committee. We will produce a report for Asthma-UK, submit papers to peer-reviewed journals and construct an interactive map.
影响因子：
3.1
作者：
Bahadori, Katayoun;Doyle-Waters, Mary M;FitzGerald, J Mark
通讯作者：
FitzGerald, J Mark
影响因子：
17.3
作者：
Anandan, C.;Gupta, R.;Sheikh, A.
通讯作者：
Sheikh, A.
影响因子：
2.1
作者：
Briggs, AH;Wonderling, DE;Mooney, CZ
通讯作者：
Mooney, CZ